» Articles » PMID: 31102363

[Mechanisms of Herpes Simplex Virus Latency and Reactivation]

Overview
Specialty General Medicine
Date 2019 May 19
PMID 31102363
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Herpes simplex virus (HSV), including HSV-1 and HSV-2, is an important pathogen that can cause many diseases. Usually these diseases are recurrent and incurable. After lytic infection on the surface of peripheral mucosa, HSV can enter sensory neurons and establish latent infection during which viral replication ceases. Moreover, latent virus can re-enter the replication cycle by reactivation and return to peripheral tissues to start recurrent infection. This ability to escape host immune surveillance during latent infection and to spread during reactivation is a viral survival strategy and the fundamental reason why no drug can completely eradicate the virus at present. Although there are many studies on latency and reactivation of HSV, and much progress has been made, many specific mechanisms of the process remain obscure or even controversial due to the complexity of this process and the limitations of research models. This paper reviews the major results of research on HSV latency and reactivation, and discusses future research directions in this field.

Citing Articles

BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines.

Iqbal A, Suryawanshi R, Yadavalli T, Volety I, Shukla D Antiviral Res. 2020; 180:104814.

PMID: 32380150 PMC: 7387215. DOI: 10.1016/j.antiviral.2020.104814.

References
1.
Neumann D, Bhattacharjee P, Giordani N, Bloom D, Hill J . In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment. J Virol. 2007; 81(23):13248-53. PMC: 2169074. DOI: 10.1128/JVI.01569-07. View

2.
Jurak I, Hackenberg M, Kim J, Pesola J, Everett R, Preston C . Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection. J Virol. 2013; 88(4):2337-9. PMC: 3911564. DOI: 10.1128/JVI.03486-13. View

3.
Ma J, Russell T, Spelman T, Carbone F, Tscharke D . Lytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional response. PLoS Pathog. 2014; 10(7):e1004237. PMC: 4110040. DOI: 10.1371/journal.ppat.1004237. View

4.
Ferenczy M, DeLuca N . Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0. J Virol. 2010; 85(7):3424-35. PMC: 3067893. DOI: 10.1128/JVI.02263-10. View

5.
Liang Y, Vogel J, Narayanan A, Peng H, Kristie T . Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med. 2009; 15(11):1312-7. PMC: 2783573. DOI: 10.1038/nm.2051. View